B-cell receptor signal strength influences terminal differentiation

European Journal of Immunology

Volumn 43, Issue 3, 2013, Pages 619-628

  Lechouane, Fabien ^a   Bonaud, Amélie ^a   Delpy, Laurent ^a   Casola, Stefano ^b   Oruc, Zeliha ^a   Chemin, Guillaume ^a,c   Cogné, Michel ^a   Sirac, Christophe ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

B cells; BCR; LMP2A; Plasma cells

Indexed keywords

B LYMPHOCYTE RECEPTOR; BETA1 INTEGRIN; CD40 ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 4; PROTEIN KINASE SYK; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; MICE; MICE, KNOCKOUT; PLASMA CELLS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SYNDECAN-1; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; VIRAL MATRIX PROTEINS;

EID: 84874957014     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242912     Document Type: Article

References (49)

1. Wang, H. and Clarke, S. H., Regulation of B-cell development by antibody specificity. Curr. Opin. Immunol. 2004. 16: 246-250.
2. Kraus, M., Alimzhanov, M. B., Rajewsky, N. and Rajewsky, K., Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004. 117: 787-800.
3. Cancro, M. P. and Kearney, J. F., B-cell positive selection: road map to the primary repertoire? J. Immunol. 2004. 173: 15-19.
4. Pillai, S., Cariappa, A. and Moran, S. T., Marginal zone B cells. Annu. Rev. Immunol. 2005. 23: 161-196.
5. Monroe, J. G., ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 2006. 6: 283-294.
6. Berland, R. and Wortis, H. H., Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002. 20: 253-300.
7. Liu, Y. J. and Banchereau, J., Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 1997. 9: 235-240.
8. McHeyzer-Williams, M. G. and Ahmed, R., B-cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 1999. 11: 172-179.
9. Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T. and Hiepe, F., Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006. 6: 741-750.
10. Oracki, S. A., Walker, J. A., Hibbs, M. L., Corcoran, L. M. and Tarlinton, D. M., Plasma cell development and survival. Immunol. Rev. 2010. 237: 140-159.
11. Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. and Brink, R., Control systems and decision making for antibody production. Nat. Immunol. 2010. 11: 681-688.
12. Grandien, A., Modigliani, Y., Coutinho, A. and Andersson, J., Suppression of B-cell differentiation by ligation of membrane-bound IgM. Eur. J. Immunol. 1993. 23: 1561-1565.
13. Knödel, M., Kuss, A. W., Berberich, I. and Schimpl, A., Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B-cell differentiation but arrests isotype switching. Eur. J. Immunol. 2001. 31: 1972-1980.
14. Rui, L., Vinuesa, C. G., Blasioli, J. and Goodnow, C. C., Resistance to CpG DNA-induced autoimmunity through tolerogenic B-cell antigen receptor ERK signaling. Nat. Immunol. 2003. 4: 594-600.
15. Rui, L., Healy, J. I., Blasioli, J. and Goodnow, C. C., ERK signaling is a molecular switch integrating opposing inputs from B-cell receptor and T-cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 2006. 177: 5337-5346.
16. Caven, T. H., Sturgill, J. L. and Conrad, D. H., BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B-cell cultures. Cell. Immunol. 2007. 247: 49-58.
17. Randall, T. D., Heath, A. W., Santos-Argumedo, L., Howard, M. C., Weissman, I. L. and Lund, F. E., Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 1998. 8: 733-742.
18. Satpathy, S., Shenoy, G. N., Kaw, S., Vaidya, T., Bal, V., Rath, S. and George, A., Inhibition of terminal differentiation of B cells mediated by CD27 and CD40 involves signaling through JNK. J. Immunol. 2010. 185: 6499-6507.
19. Paus, D., Phan, T. G., Chan, T. D., Gardam, S., Basten, A. and Brink, R., Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B-cell differentiation. J. Exp. Med. 2006. 203: 1081-1091.
20. Phan, T. G., Paus, D., Chan, T. D., Turner, M. L., Nutt, S. L., Basten, A. and Brink, R., High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 2006. 203: 2419-2424.
21. Tsubata, T., Molecular mechanisms for apoptosis induced by signaling through the B-cell antigen receptor. Int. Rev. Immunol. 2001. 20: 791-803.
22. Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., Carroll, M. C. et al., B-cell receptor signal strength determines B-cell fate. Nat. Immunol. 2004. 5: 317-327.
23. Caldwell, R. G., Wilson, J. B., Anderson, S. J. and Longnecker, R., Epstein-Barr virus LMP2A drives B-cell development and survival in the absence of normal B-cell receptor signals. Immunity 1998. 9: 405-411.
24. Sirac, C., Carrion, C., Duchez, S., Comte, I. and Cogné, M., Light chain inclusion permits terminal B-cell differentiation and does not necessarily result in autoreactivity. Proc. Natl. Acad. Sci. USA 2006. 103: 7747-7752.
25. Sirac, C., Bridoux, F., Carrion, C., Devuyst, O., Fernandez, B., Goujon, J.-M., El Hamel, C. et al., Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 2006. 108: 536-543.
26. Agenès, F. and Freitas, A. A., Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B-cell population. J. Exp. Med. 1999. 189: 319-330.
27. Walter, J. E., Rucci, F., Patrizi, L., Recher, M., Regenass, S., Paganini, T., Keszei, M. et al., Expansion of immunoglobulin-secreting cells and defects in B-cell tolerance in Rag-dependent immunodeficiency. J. Exp. Med. 2010. 207: 1541-1554.
28. Jiang, Y., Hirose, S., Sanokawa-Akakura, R., Abe, M., Mi, X., Li, N., Miura, Y. et al., Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol. 1999. 11: 1685-1691.
29. Oliver, A. M., Martin, F. and Kearney, J. F., IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999. 162: 7198-7207.
30. Genestier, L., Taillardet, M., Mondiere, P., Gheit, H., Bella, C. and Defrance, T., TLR agonists selectively promote terminal plasma cell differentiation of B-cell subsets specialized in thymus-independent responses. J. Immunol. 2007. 178: 7779-7786.
31. Yamamoto, N., Takeshita, K., Shichijo, M., Kokubo, T., Sato, M., Nakashima, K., Ishimori, M. et al., The orally available spleen tyrosine kinase inhibitor 2-[7-(3, 4-dimethoxyphenyl)-imidazo[1, 2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. J. Pharmacol. Exp. Ther. 2003. 306: 1174-1181.
32. Imai, T., Jiang, M., Chambon, P. and Metzger, D., Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA 2001. 98: 224-228.
33. Fairfax, K. A., Corcoran, L. M., Pridans, C., Huntington, N. D., Kallies, A., Nutt, S. L. and Tarlinton, D. M., Different kinetics of blimp-1 induction in B-cell subsets revealed by reporter gene. J. Immunol. 2007. 178: 4104-4111.
34. Pillai, S., Cariappa, A. and Moran, S. T., Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 2004. 197: 206-218.
35. Wong, S.-C., Chew, W.-K., Tan, J. E.-L., Melendez, A. J., Francis, F. and Lam, K.-P., Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 2002. 277: 30707-30715.
36. Yang, Y., Tung, J. W., Ghosn, E. E. B., Herzenberg, L. A. and Herzenberg, L. A., Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 2007. 104: 4542-4546.
37. Merchant, M., Caldwell, R. G. and Longnecker, R., The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 2000. 74: 9115-9124.
38. Portis, T., Cooper, L., Dennis, P. and Longnecker, R., The LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Front. Biosci. 2002. 7: d414-d426.
39. Portis, T. and Longnecker, R., Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 2004. 23: 8619-8628.
40. Engels, N., Yigit, G., Emmerich, C. H., Czesnik, D., Schild, D. and Wienands, J., Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B-cell antigen receptor-like activation signal. Cell Commun. Signal. 2012. 10: 9.
41. Merchant, M., Swart, R., Katzman, R. B., Ikeda, M., Ikeda, A., Longnecker, R., Dykstra, M. L. et al. The effects of the Epstein-Barr virus latent membrane protein 2A on B-cell function. Int. Rev. Immunol. 2001. 20: 805-835.
42. Hermiston, M. L., Xu, Z. and Weiss, A., CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 2003. 21: 107-137.
43. Poe, J. C., Hasegawa, M. and Tedder, T. F., CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 2001. 20: 739-762.
44. Tarlinton, D., Radbruch, A., Hiepe, F. and Dörner, T., Plasma cell differentiation and survival. Curr. Opin. Immunol. 2008. 20: 162-169.
45. Bernasconi, N. L., Traggiai, E. and Lanzavecchia, A., Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002. 298: 2199-2202.
46. Thorley-Lawson, D. A., Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001. 1: 75-82.
47. Merchant, M., Swart, R., Katzman, R. B., Ikeda, M., Ikeda, A., Longnecker, R., Dykstra, M. L. et al., The effects of the Epstein-Barr virus latent membrane protein 2A on B-cell function. Int. Rev. Immunol. 2001. 20: 805-835.
48. Laichalk, L. L. and Thorley-Lawson, D. A., Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005. 79: 1296-1307.
49. Goldman, J. P., Blundell, M. P., Lopes, L., Kinnon, C., Di Santo, J. P. and Thrasher, A. J., Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br. J. Haematol. 1998. 103: 335-342.